Aktiesnakken — August 2010
-
nej
-
ikke udover min egen dialog med Sydbank
-
AMA passer godt ind til Sydbank
-
Sydbank er ikke forstore til at købe ama
-
for store
-
ud af en arbejdende kapital så sidder SYD på nuværende tidspunkt kun på 4% i DK
-
Sydbank
-
For 2010 venter Genmab en omsætning eksklusive royalties fra salg af Arzerra på ca. 350-450 mio. kr.,
-
samt at driftsunderskuddet for fortsættende aktiviteter vil ligge i niveauet 550-650 mio. kr.
-
Har kun deres egne forventninger indtil videre...
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind